Letter: potential selection bias in real-world comparison of ustekinumab versus vedolizumab as a second-line treatment for Crohn's disease-authors' reply.
作者信息
Selinger Christian P, Lenti Marco Vincenzo, De Silvestri Annalisa
机构信息
Department of Gastroenterology, Leeds Teaching Hospitals, Leeds, UK.
Department of Internal Medicine, IRCCS San Matteo Hospital Foundation, University of Pavia, Pavia, Italy.
出版信息
Aliment Pharmacol Ther. 2022 Apr;55(8):1070-1071. doi: 10.1111/apt.16896.
PMID:35362123
Abstract
摘要
Zotero 插件